Clinical Trial Update: CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort Study

View source ↗

Summary

A retrospective cohort study evaluates CurQD as add-on therapy to vedolizumab in ulcerative colitis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• CurQD
• Entyvio (vedolizumab)

Snippet

Sponsor: Evinature Ltd. | Conditions: Ulcerative Colitis (UC) | Status: ACTIVE_NOT_RECRUITING